Exobiosphere Earns Coveted Spot in Fit 4 Start's 12th Edition
Luxembourg, October 2024 – Exobiosphere, a pioneering company leveraging biotechnology in space for pharmaceutical and skincare innovation, is proud to announce its selection as one of the 20 startups chosen for the prestigious 12th edition of Luxembourg’s Fit 4 Start accelerator program. This recognition reaffirms Exobiosphere's role in revolutionizing high-throughput drug discovery and cutting-edge formulations through microgravity research.
Fit 4 Start, Luxembourg’s flagship program, provides selected startups with crucial resources including funding, mentorship, and access to a robust network of industry experts. Exobiosphere will benefit from personalized support designed to accelerate its development and expand its technological breakthroughs, enhancing the company's ability to develop novel products in the health and beauty sectors.
“Being part of Fit 4 Start is a significant milestone for Exobiosphere. This platform gives us the opportunity to accelerate our vision of transforming drug discovery and beauty innovation through space-based research. With Luxembourg’s dynamic ecosystem and strategic backing, we are more empowered than ever to push the boundaries of what’s possible,” said Kyle Acierno, CEO of Exobiosphere.
Olivia Borgue, Director of Engineering for Exobiosphere, echoed this sentiment: “Fit 4 Start’s support will be invaluable as we develop our proprietary high-throughput screening technologies. This selection not only validates our mission but also provides the guidance and resources we need to scale our solutions globally.”
Exobiosphere looks forward to collaborating with key stakeholders and further driving innovation within Luxembourg’s thriving space and biotechnology sectors. Through the Fit 4 Start program, Exobiosphere is committed to making groundbreaking advancements that will improve lives across the pharmaceutical, beauty, and healthcare industries.
About Exobiosphere:
Exobiosphere is at the forefront of biotechnology in space, specializing in high-throughput testing and microgravity research to create innovative solutions for drug discovery and skincare. The company’s cutting-edge approach enables the development of novel formulations and therapies that address unmet needs in the pharmaceutical and beauty sectors.